A patient received a 10x higher dose of Hydromorphone 3 hours ago and is currently asymptomatic. What is the best next step?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

A patient received a 10x higher dose of Hydromorphone 3 hours ago and is currently asymptomatic. What is the best next step?

Explanation:
The key idea is matching treatment to the drug’s duration and the patient’s current status. Hydromorphone is a short-acting opioid, so its toxic effects typically appear early and diminish as the drug clears. If a patient who has taken a large overdose is asymptomatic after several hours, there is no ongoing toxicity to reverse. The best course is to monitor and ensure airway, breathing, and circulation, since nothing in the scenario now calls for antidotal reversal. Giving naloxone would be reserved for signs of opioid toxicity such as respiratory depression or altered mental status; administering it to an asymptomatic patient risks unnecessary reversal of analgesia and possible withdrawal effects. Activated charcoal is most beneficial if the ingestion window is still within a short time frame when absorption may continue; after several hours, its benefit is minimal. Inducing vomiting is generally avoided due to aspiration risk and is not indicated when the patient is not actively ingesting or symptomatic. So, no additional steps are needed beyond observation and standard supportive monitoring.

The key idea is matching treatment to the drug’s duration and the patient’s current status. Hydromorphone is a short-acting opioid, so its toxic effects typically appear early and diminish as the drug clears. If a patient who has taken a large overdose is asymptomatic after several hours, there is no ongoing toxicity to reverse. The best course is to monitor and ensure airway, breathing, and circulation, since nothing in the scenario now calls for antidotal reversal.

Giving naloxone would be reserved for signs of opioid toxicity such as respiratory depression or altered mental status; administering it to an asymptomatic patient risks unnecessary reversal of analgesia and possible withdrawal effects. Activated charcoal is most beneficial if the ingestion window is still within a short time frame when absorption may continue; after several hours, its benefit is minimal. Inducing vomiting is generally avoided due to aspiration risk and is not indicated when the patient is not actively ingesting or symptomatic.

So, no additional steps are needed beyond observation and standard supportive monitoring.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy